Phosphoinositide 3-kinase inhibitor compounds and methods of use
US8450315B2 · kind B2 · utility
9Cited by
12References
49Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 29, 2010 |
| Grant date | May 28, 2013 |
| Priority date | — |
| Expiry date | Oct 29, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of using compounds of Formula Ia and Ib for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.